Top Page
GMO GlobalSign Holdings K.K.
(3788)
GMO GlobalSign Holdings K.K. (3788) vs. iShares MSCI Japan ETF (EWJ)
GMO GlobalSign Holdings K.K. Business Overview & Revenue Model
GMO GlobalSign Holdings K.K. Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.54B | 20.67B | 19.17B | 17.50B | 15.96B | 14.05B |
| Gross Profit | 11.58B | 12.20B | 11.54B | 10.94B | 9.68B | 8.44B |
| EBITDA | 2.63B | 3.19B | 2.86B | 2.59B | 2.31B | 1.73B |
| Net Income | 760.55M | 1.01B | 854.56M | 739.69M | 846.76M | 483.62M |
Balance Sheet | ||||||
| Total Assets | 17.83B | 18.96B | 18.03B | 15.69B | 14.57B | 11.51B |
| Cash, Cash Equivalents and Short-Term Investments | 8.49B | 8.94B | 8.46B | 6.66B | 6.68B | 5.04B |
| Total Debt | 3.29B | 2.70B | 3.02B | 2.01B | 1.96B | 693.48M |
| Total Liabilities | 8.55B | 8.61B | 8.54B | 7.03B | 6.62B | 4.36B |
| Stockholders Equity | 9.25B | 10.33B | 9.46B | 8.64B | 7.93B | 7.13B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.68B | 1.23B | 267.18M | 293.69M | 327.16M |
| Operating Cash Flow | 0.00 | 2.84B | 2.81B | 2.20B | 1.68B | 1.56B |
| Investing Cash Flow | 0.00 | -1.58B | -1.60B | -1.80B | -1.14B | -1.19B |
| Financing Cash Flow | 0.00 | -822.52M | 280.79M | -645.92M | 763.68M | -822.04M |
GMO GlobalSign Holdings K.K. Technical Analysis
GMO GlobalSign Holdings K.K. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥20.55B | 21.48 | ― | 0.90% | 17.75% | 44.95% | |
69 Neutral | ¥19.05B | 23.88 | ― | 2.13% | -0.62% | -11.36% | |
65 Neutral | ¥32.20B | 10.11 | 10.34% | 4.82% | -3.03% | 38.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥23.50B | 24.03 | ― | 1.50% | 7.83% | 49.73% | |
60 Neutral | ¥5.91B | 31.61 | ― | 1.04% | -3.46% | -59.98% | |
50 Neutral | ¥1.59B | -2.73 | ― | ― | 5.17% | ― |
GMO GlobalSign Holdings K.K. Corporate Events
GMO GlobalSign Holdings K.K. has resolved to propose an amendment to its Articles of Incorporation that would change the total number of authorized shares, to be voted on at the annual shareholders meeting on March 17, 2026. The company plans to reduce its authorized shares from 34,360,000 to 11,909,980, aiming to maintain an appropriate capital structure and secure flexibility in capital policy in light of future changes in its management environment and the impact on shareholder value.
The decision reflects management’s focus on aligning its equity base with long-term capital strategy and market conditions, suggesting a more disciplined approach to share issuance going forward. If approved, the amendment will take effect immediately on the date of the shareholders meeting, potentially influencing future financing options, dilution dynamics, and overall capital efficiency for existing and prospective investors.
The most recent analyst rating on (JP:3788) stock is a Buy with a Yen2684.00 price target. To see the full list of analyst forecasts on GMO GlobalSign Holdings K.K. stock, see the JP:3788 Stock Forecast page.
GMO GlobalSign Holdings K.K. has approved a proposal to distribute year-end dividends from retained earnings for the fiscal year ended December 31, 2025, setting the payment at ¥56.91 per share, up from ¥37.22 a year earlier. The total planned dividend payout is ¥653 million, with an effective payment date of March 23, 2026, pending approval at the March 17 annual shareholders meeting.
The company reiterated its policy of prioritizing both internal funding for future business expansion and organizational strengthening while maintaining stable shareholder returns, targeting a consolidated dividend payout ratio of 65% or more. The higher year-end dividend underscores management’s commitment to that policy and signals confidence in the firm’s financial performance and cash-generation capacity for stakeholders.
The most recent analyst rating on (JP:3788) stock is a Buy with a Yen2684.00 price target. To see the full list of analyst forecasts on GMO GlobalSign Holdings K.K. stock, see the JP:3788 Stock Forecast page.
GMO GlobalSign Holdings reported record-high sales and operating profit for FY2025, driven by strong performance of key products and a business model centered on recurring revenue. The company expects continued steady growth in revenue and profit, aims to further expand market share and improve pricing, and has revised its projected dividend upward while adopting a Dividend on Equity standard from FY2026 to enhance shareholder returns.
These moves underscore management’s confidence in the sustainability of earnings and signal a more shareholder-focused capital policy, which may strengthen the company’s market positioning and appeal to investors seeking both growth and income. The emphasis on recurring revenue and price optimization suggests a strategy geared toward resilience and profitability in a competitive digital services landscape.
The most recent analyst rating on (JP:3788) stock is a Buy with a Yen2684.00 price target. To see the full list of analyst forecasts on GMO GlobalSign Holdings K.K. stock, see the JP:3788 Stock Forecast page.
GMO GlobalSign Holdings reported consolidated net sales of ¥20.67 billion for the year ended 31 December 2025, up 7.9% year on year, with operating profit rising 18.3% to ¥1.48 billion and profit attributable to owners of parent climbing 17.6% to ¥1.01 billion. The company strengthened its financial position as total assets increased to ¥18.96 billion, equity ratio improved to 54.5% and cash and cash equivalents rose to ¥9.03 billion, supporting a higher year-end dividend of ¥56.91 per share and implying an elevated payout ratio of 65.0%.
Management forecast further growth in 2026, guiding for net sales of ¥22.29 billion, a 7.8% increase, and a 10.0% rise in operating profit to ¥1.62 billion, while earnings per share are projected to reach ¥91.79. The outlook suggests GMO GlobalSign aims to balance continued earnings expansion with shareholder returns, as the company maintains its dividend policy and signals confidence in its ability to generate stable cash flows in its core digital services business.
The most recent analyst rating on (JP:3788) stock is a Buy with a Yen2684.00 price target. To see the full list of analyst forecasts on GMO GlobalSign Holdings K.K. stock, see the JP:3788 Stock Forecast page.
GMO GlobalSign Holdings reported that non-consolidated net sales for the fiscal year ended December 31, 2025 rose 13.7% year on year to ¥9.3 billion, driven mainly by strong demand for its GMO Sign e-contract service and CloudCREW byGMO managed cloud offering. Profitability also improved significantly, with ordinary profit climbing 69.8% to ¥698 million and net income rising 69.1% to ¥645 million, and the company has set a higher year-end dividend of ¥56.91 per share, underscoring confidence in its earnings momentum.
The strong performance in its core digital certificate, e-signature and cloud infrastructure segments highlights GMO GlobalSign Holdings’ strengthening position in Japan’s digital transformation and cloud services markets. The combination of double-digit top-line growth, sharply higher profits and an increased dividend suggests improving operational leverage and offers a positive signal to shareholders regarding the company’s growth trajectory and capital return policy.
The most recent analyst rating on (JP:3788) stock is a Buy with a Yen2684.00 price target. To see the full list of analyst forecasts on GMO GlobalSign Holdings K.K. stock, see the JP:3788 Stock Forecast page.
GMO GlobalSign Holdings has completed a share repurchase program conducted under Japan’s Companies Act, buying back 11,900 shares of its common stock for a total of JPY 26.66 million between January 1 and January 30, 2026, via market purchases through a securities firm. The program, authorized in November 2025 for up to 45,000 shares and JPY 150 million, concluded below its maximum limits, signaling a measured approach to capital allocation as the company balances business growth with efforts to enhance shareholder returns and optimize its capital structure.
The buyback’s relatively modest scale versus the authorized ceiling suggests management is preserving financial flexibility while still demonstrating a commitment to shareholder value. For investors, the completed repurchase provides incremental support to earnings per share and indicates the company’s continued use of share buybacks as a tool within its broader shareholder-return policy, without significantly altering its overall equity base or leverage profile.
The most recent analyst rating on (JP:3788) stock is a Buy with a Yen2684.00 price target. To see the full list of analyst forecasts on GMO GlobalSign Holdings K.K. stock, see the JP:3788 Stock Forecast page.
GMO GlobalSign Holdings has announced an upward revision to its year-end dividend forecast for the fiscal year ended December 31, 2025, following a resolution at an extraordinary Board of Directors meeting on February 10, 2026. In line with its policy of shareholder returns via performance-linked dividends targeting a payout ratio of about 65% of net income attributable to owners of the parent, the company raised its projected year-end dividend from ¥49.84 to ¥56.91 per share, compared with ¥37.22 per share in the previous fiscal year, signaling stronger earnings and an enhanced commitment to shareholder returns.
The most recent analyst rating on (JP:3788) stock is a Buy with a Yen2684.00 price target. To see the full list of analyst forecasts on GMO GlobalSign Holdings K.K. stock, see the JP:3788 Stock Forecast page.
GMO GlobalSign Holdings has revised its shareholder return policy, introducing Dividend on Equity (DOE) as an additional metric alongside its existing consolidated dividend payout ratio. The company aims to provide stable and consistent dividends by targeting the higher of a 65% consolidated payout ratio or a 4% DOE, based on equity excluding foreign currency translation adjustments.
This new framework, effective from the fiscal year ending December 31, 2026, is designed to clarify the firm’s commitment to shareholder returns and align distributions more closely with its equity base. The move may enhance visibility and predictability of dividends for investors, potentially strengthening shareholder trust and supporting the company’s capital market positioning over the medium term.
The most recent analyst rating on (JP:3788) stock is a Buy with a Yen2684.00 price target. To see the full list of analyst forecasts on GMO GlobalSign Holdings K.K. stock, see the JP:3788 Stock Forecast page.
GMO GlobalSign Holdings has disclosed that, during the period from December 1 to December 31, 2025, it did not repurchase any of its own shares under its previously approved share buyback program, resulting in zero shares acquired and no capital deployed so far. The buyback authorization, approved by the board on November 12, 2025, allows for the purchase of up to 45,000 shares or ¥150 million through January 30, 2026, meaning the company still has full capacity under the program and may yet use share repurchases as a capital allocation tool, with potential implications for shareholder returns and market perception of the stock.
The most recent analyst rating on (JP:3788) stock is a Buy with a Yen2684.00 price target. To see the full list of analyst forecasts on GMO GlobalSign Holdings K.K. stock, see the JP:3788 Stock Forecast page.
GMO GlobalSign Holdings K.K. announced an interim report on its share repurchase program, revealing that no shares were repurchased between November 17 and November 30, 2025. Despite the lack of repurchase activity, the company plans to continue its share buyback initiative, which was approved by the Board of Directors, allowing for the repurchase of up to 45,000 shares by January 30, 2026. This move is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (JP:3788) stock is a Buy with a Yen2684.00 price target. To see the full list of analyst forecasts on GMO GlobalSign Holdings K.K. stock, see the JP:3788 Stock Forecast page.